stoxline Quote Chart Rank Option Currency Glossary
  
Medpace Holdings, Inc. (MEDP)
340.175  -2.235 (-0.65%)    02-14 16:00
Open: 342.74
High: 344.99
Volume: 278,414
  
Pre. Close: 342.41
Low: 338.185
Market Cap: 10,364(M)
Technical analysis
2025-02-14 4:49:42 PM
Short term     
Mid term     
Targets 6-month :  414.34 1-year :  438
Resists First :  354.74 Second :  375
Pivot price 346.69
Supports First :  321.98 Second :  267.88
MAs MA(5) :  340.28 MA(20) :  346.12
MA(100) :  340.8 MA(250) :  371.79
MACD MACD :  -0.4 Signal :  1
%K %D K(14,3) :  33.3 D(3) :  28.9
RSI RSI(14): 47.2
52-week High :  459.76 Low :  302.01
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ MEDP ] has closed above bottom band by 29.7%. Bollinger Bands are 23.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 345.39 - 347.21 347.21 - 348.76
Low: 333.86 - 335.93 335.93 - 337.69
Close: 336.78 - 340.29 340.29 - 343.27
Company Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Headline News

Sat, 15 Feb 2025
Arcus Capital Partners LLC Invests $321,000 in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Sat, 15 Feb 2025
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Bought by Savant Capital LLC - MarketBeat

Sat, 15 Feb 2025
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Acquired by Davidson Capital Management Inc. - MarketBeat

Fri, 14 Feb 2025
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Sold by Shaker Investments LLC OH - MarketBeat

Fri, 14 Feb 2025
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Yahoo Finance

Fri, 14 Feb 2025
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 Earnings Call Transcript - MSN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 31 (M)
Shares Float 25 (M)
Held by Insiders 17.8 (%)
Held by Institutions 85 (%)
Shares Short 1,000 (K)
Shares Short P.Month 1,170 (K)
Stock Financials
EPS 11.42
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 28.42
Profit Margin 17.6 %
Operating Margin 21 %
Return on Assets (ttm) 14.3 %
Return on Equity (ttm) 54 %
Qtrly Rev. Growth 8.3 %
Gross Profit (p.s.) 44.72
Sales Per Share 66.6
EBITDA (p.s.) 14.07
Qtrly Earnings Growth 35.5 %
Operating Cash Flow 575 (M)
Levered Free Cash Flow 438 (M)
Stock Valuations
PE Ratio 29.78
PEG Ratio 0
Price to Book value 11.96
Price to Sales 5.1
Price to Cash Flow 18.4
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android